AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,578.00p
   
  • Change Today:
    -14.00p
  • 52 Week High: 14,148.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.73m
  • Volume: 3,865,312
  • Market Cap: £210,558m
  • RiskGrade: 123

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
04-Dec-25 JP Morgan Cazenove Overweight 13,514.00p - 14,000.00p Reiteration
10-Nov-25 Jefferies Buy 13,126.00p 15,000.00p 15,000.00p Reiteration
06-Nov-25 Shore Capital Buy 12,834.00p - 14,500.00p Reiteration
21-Oct-25 Berenberg Bank Buy 12,474.00p 14,200.00p 14,500.00p Reiteration
30-Jul-25 Deutsche Hold 11,498.00p - 11,000.00p Reiteration
28-May-24 Citigroup Buy 12,028.00p - - Reiteration
08-Apr-24 Barclays Overweight 10,610.00p - 12,500.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,578.00p
Change Today -14.00p
% Change -0.10 %
52 Week High 14,148.00p
52 Week Low 9,667.00p
Volume 3,865,312
Shares Issued 1,550.73m
Market Cap £210,558m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 08-Dec-2025

Time Volume / Share Price
16:22 0 @ 13,564.00p
16:22 0 @ 13,566.00p
15:47 0 @ 13,538.00p
15:59 0 @ 13,516.00p
15:22 0 @ 13,524.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page